Advertisement
Screener

AYTU BIOPHARMA, INC (AYTU) Form CORRESP: Company correspondence with SEC staff

2.2 / 5 stars · 38/87 Roast Me

Add as a preferred source on Google

AYTU BIOPHARMA, INC Form CORRESP: Company correspondence with SEC staff

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2025-06-02: Form CORRESP; Description Company correspondence with SEC staff; Document filename1.htm.
  • 2025-06-02: Form CORRESP; Description Company correspondence with SEC staff; Document filename1.htm.
  • 2024-10-07: Form CORRESP; Description Company correspondence with SEC staff; Document filename1.htm.
  • 2023-06-07: Form CORRESP; Description Company correspondence with SEC staff; Document filename1.htm.
FiledFormPeriod of reportDescriptionDocument
2025-06-02CORRESPCompany correspondence with SEC stafffilename1.htm
2025-06-02CORRESPCompany correspondence with SEC stafffilename1.htm
2024-10-07CORRESPCompany correspondence with SEC stafffilename1.htm
2023-06-07CORRESPCompany correspondence with SEC stafffilename1.htm
2023-06-07CORRESPCompany correspondence with SEC stafffilename1.htm
2022-06-16CORRESPCompany correspondence with SEC stafffilename1.htm
2022-02-22CORRESPCompany correspondence with SEC stafffilename1.htm
2022-02-14CORRESPCompany correspondence with SEC stafffilename1.htm
2022-02-02CORRESPCompany correspondence with SEC stafffilename1.htm
2021-10-06CORRESPCompany correspondence with SEC stafffilename1.htm
2021-02-08CORRESPCompany correspondence with SEC stafffilename1.htm
2020-06-12CORRESPCompany correspondence with SEC stafffilename1.htm
2020-06-12CORRESPCompany correspondence with SEC stafffilename1.htm
2020-02-27CORRESPCompany correspondence with SEC stafffilename1.htm
2020-01-14CORRESPCompany correspondence with SEC stafffilename1.htm
2020-01-07CORRESPCompany correspondence with SEC stafffilename1.htm
2019-12-31CORRESPCompany correspondence with SEC stafffilename1.htm
2019-11-21CORRESPCompany correspondence with SEC stafffilename1.htm
2018-10-03CORRESPCompany correspondence with SEC stafffilename1.htm
2018-05-07CORRESPCompany correspondence with SEC stafffilename1.htm
2018-02-28CORRESPCompany correspondence with SEC stafffilename1.htm
2018-02-28CORRESPCompany correspondence with SEC stafffilename1.htm
2017-11-30CORRESPCompany correspondence with SEC stafffilename1.htm
2017-10-23CORRESPCompany correspondence with SEC stafffilename1.htm
2017-09-22CORRESPCompany correspondence with SEC stafffilename1.htm
2016-10-26CORRESPCompany correspondence with SEC stafffilename1.htm
2016-10-26CORRESPCompany correspondence with SEC stafffilename1.htm
2016-10-21CORRESPCompany correspondence with SEC stafffilename1.htm
2016-10-21CORRESPCompany correspondence with SEC stafffilename1.htm
2016-10-11CORRESPCompany correspondence with SEC stafffilename1.htm
2016-09-16CORRESPCompany correspondence with SEC stafffilename1.htm
2016-06-28CORRESPCompany correspondence with SEC stafffilename1.htm
2016-04-29CORRESPCompany correspondence with SEC stafffilename1.htm
2016-04-29CORRESPCompany correspondence with SEC stafffilename1.htm
2016-04-01CORRESPCompany correspondence with SEC stafffilename1.htm
2016-03-30CORRESPCompany correspondence with SEC stafffilename1.htm
2016-03-09CORRESPCompany correspondence with SEC stafffilename1.htm
2015-10-22CORRESPCompany correspondence with SEC stafffilename1.htm
2015-08-07CORRESPCompany correspondence with SEC stafffilename1.htm
2015-07-30CORRESPCompany correspondence with SEC stafffilename1.htm
2007-05-08CORRESPCompany correspondence with SEC stafffilename1.htm
2007-05-03CORRESPCompany correspondence with SEC stafffilename1.htm

Similar stocks

Stock NameCountryMarket CapPE Ratio
NextCure, Inc. (NXTC)United States$0.024B-0.15
TherapeuticsMD, Inc. (TXMD)United States$0.024B-117.87
ARTELO BIOSCIENCES, INC. (ARTL)United States$0.023B
KYNTRA BIO, INC. (KYNB)United States$0.028B0.17
Transcode Therapeutics, Inc. (RNAZ)United States$0.029B-0.12
Cocrystal Pharma, Inc. (COCP)United States$0.022B
Hepion Pharmaceuticals, Inc. (HEPA)United States$0.029B-0.62
ATOSSA THERAPEUTICS, INC. (ATOS)United States$0.021B-0.52
IGC Pharma, Inc. (IGC)United States$0.029B-5.98
Neuphoria Therapeutics Inc. (NEUP)United States$0.020B-1.77
Advertisement